Journal of Precision Biosciences

1.Introduction

Cells exist in environments that are rarely static. Nutrient levels fluctuate, oxidative stress rises and falls, and signals from neighboring cells constantly reshape cellular priorities. To cope with this shifting landscape, living systems rely on intricate regulatory frameworks capable of sensing environmental cues and converting them into coordinated biochemical responses. Signal transduction pathways form the core of this adaptive machinery, linking extracellular stimuli with intracellular decision-making processes. Through these networks, cells translate environmental changes into alterations in metabolism, gene expression, and protein function, allowing them to maintain homeostasis while responding to stress or developmental signals (Ruta et al., 2021; Dmitrenko et al., 2022).

At first glance, cellular adaptation might appear to depend largely on transcriptional regulation—simply turning genes on or off as needed. Yet the reality is more nuanced. Transcriptional responses, although powerful, are comparatively slow and energetically demanding. Cells often require mechanisms that operate on much shorter timescales. Post-translational modifications (PTMs) provide such flexibility. By chemically modifying pre-existing proteins, PTMs can rapidly alter protein activity, stability, localization, or interaction networks. In effect, they function as molecular switches that fine-tune cellular behavior without requiring new protein synthesis (Cappadocia & Lima, 2018; Flotho & Melchior, 2013).

Among the many PTMs identified, phosphorylation has historically received the most attention. Protein kinases and phosphatases form complex regulatory circuits that govern almost every aspect of cellular physiology. Advances in phosphoproteomics have revealed just how extensive these regulatory networks are, uncovering thousands of phosphorylation events that collectively shape cellular signaling landscapes (DeMarco & Hall, 2023). In classical signaling cascades—such as the RAS/MAPK pathway—sequential phosphorylation events propagate signals from cell-surface receptors to nuclear transcription factors, enabling cells to respond to growth factors, cytokines, and other extracellular stimuli. Unsurprisingly, disruptions in these pathways frequently contribute to disease, particularly cancer, where aberrant kinase signaling promotes uncontrolled proliferation and survival (Bray et al., 2024; Chen et al., 2023).

However, phosphorylation does not act in isolation. Over the past two decades, it has become increasingly evident that multiple PTMs cooperate to regulate protein behavior. One modification that has attracted considerable interest is SUMOylation, the covalent attachment of small ubiquitin-like modifier (SUMO) proteins to lysine residues on target proteins. Although structurally related to ubiquitination, SUMOylation typically regulates protein interactions, localization, and transcriptional activity rather than directing proteins toward degradation. The SUMO conjugation cycle—mediated by E1-activating, E2-conjugating, and E3-ligating enzymes—creates a tightly controlled system capable of rapidly responding to cellular stress or developmental signals (Geiss-Friedlander & Melchior, 2007; Wild et al., 2024).

SUMOylation has emerged as a central regulatory mechanism in many biological contexts. In nuclear receptor signaling, for example, SUMO modification can alter receptor activity and chromatin interactions, thereby shaping transcriptional outcomes. Dysregulation of SUMO pathways has also been implicated in various cancers, including thyroid malignancies, where altered SUMO enzyme activity contributes to tumor progression and changes in transcriptional regulation (Jiaerken et al., 2024). At the same time, SUMOylation appears to play protective roles in certain physiological contexts. In the nervous system, it participates in maintaining protein homeostasis and may mitigate the formation of toxic protein aggregates associated with neurodegenerative disorders (Anderson et al., 2017).

The functional consequences of PTMs extend beyond protein signaling to encompass broader regulatory processes such as gene expression and RNA metabolism. Signal transduction pathways frequently intersect with RNA processing mechanisms, coordinating transcription with splicing, polyadenylation, and other post-transcriptional events. These interactions allow cells to adjust gene expression programs rapidly and precisely in response to changing conditions (Ruta et al., 2021). Alternative splicing, in particular, plays a crucial role in expanding proteomic diversity. Splicing regulators integrate signals from kinases and chromatin modifiers to determine splice-site selection, thereby generating distinct protein isoforms from the same gene (Black, 2003).

Chromatin-associated regulatory proteins further illustrate the interplay between signaling pathways and transcriptional control. The lysine acetyltransferase p300, for instance, functions as a key transcriptional co-activator that integrates signaling cues with epigenetic regulation. By modifying histones and transcription factors, p300 facilitates enhancer activation and transcriptional initiation. In prostate cancer, interactions between p300 and the androgen receptor promote the expression of oncogenic gene fusions such as TMPRSS2:ERG, highlighting the role of PTM-dependent transcriptional regulation in disease development (Gioukaki et al., 2023).

Interestingly, the regulatory logic underlying signal transduction and PTMs is not confined to eukaryotic cells. Microorganisms employ equally sophisticated signaling systems to coordinate their responses to environmental changes. In pathogenic bacteria such as *Staphylococcus aureus*, complex regulatory circuits control virulence, metabolism, and adaptation to host environments. Genome-scale analyses have revealed how these signaling systems contribute to the persistence of multidrug-resistant strains, including methicillin-resistant *S. aureus* (MRSA) (Dmitrenko et al., 2022; Scurtu et al., 2022). The evolutionary success of such pathogens reflects the efficiency with which microbial cells integrate environmental signals into coordinated physiological responses.

Surface proteins and adhesion factors also play critical roles in bacterial signaling and pathogenicity. In *S. aureus*, these molecules mediate interactions with host tissues and immune defenses, facilitating colonization and infection (Foster et al., 2014; Wang & Matunis, 2024). Over time, the accumulation of genetic and regulatory adaptations has led to the emergence of highly successful lineages of MRSA that spread globally in both healthcare and community settings (Enright et al., 2002). Such examples illustrate how signal transduction networks drive microbial evolution and adaptation.

Beyond signaling itself, PTMs have also shaped the discovery of bioactive natural products. Ribosomally synthesized and post-translationally modified peptides (RiPPs) represent a remarkable class of biomolecules whose biological activity often depends on complex PTM-mediated structural modifications. These peptides exhibit diverse pharmacological properties, including antimicrobial and anticancer activities (Arnison et al., 2013; Luo & Dong, 2019). Recent research has highlighted plant-derived RiPPs as promising therapeutic candidates, demonstrating potent cytotoxic effects against tumor cells while offering new opportunities for drug development (Hwang et al., 2025).

Specific cyclopeptides illustrate how PTM-driven structural modifications can influence biological function. Compounds such as rubipodanin A and moroidin exhibit distinctive conformations and bioactivities that arise from subtle chemical modifications during biosynthesis (Wang et al., 2015; Xu et al., 2022). These molecules provide compelling examples of how nature exploits PTMs not only for regulatory signaling but also for generating chemically diverse metabolites with therapeutic potential.

From an evolutionary perspective, the emergence of PTM-based regulation may have deep biochemical roots. Even simple peptides—once thought to be largely inert—can display catalytic or regulatory properties. Studies of primitive peptide systems suggest that short sequences may have served as early catalysts in prebiotic environments, potentially laying the groundwork for the sophisticated enzymatic networks observed in modern cells (Wieczorek et al., 2017; Sangiorgio et al., 2024). Although speculative, such findings hint that contemporary signaling pathways may reflect ancient biochemical strategies refined over billions of years.

The biomedical significance of these regulatory systems is becoming increasingly clear. Diseases ranging from cancer to neurodegeneration often arise when signaling networks lose their delicate balance. In neurodegenerative disorders, for instance, failures in protein quality control mechanisms allow misfolded proteins to accumulate and aggregate within neurons. PTMs, including SUMOylation and phosphorylation, are deeply involved in maintaining proteostasis and directing damaged proteins toward refolding or degradation pathways (Gestwicki & Garza, 2012).

Taken together, these observations underscore the central role of signal transduction and post-translational modifications in cellular adaptation. Rather than acting as isolated mechanisms, signaling pathways, PTMs, transcriptional regulators, and metabolic networks form an integrated regulatory system that allows cells to respond dynamically to environmental and physiological challenges. In this narrative review, we examine current insights into how these interconnected mechanisms govern cellular adaptation across diverse biological contexts—from microbial pathogenesis to cancer biology and neurodegenerative disease. By synthesizing evidence from molecular biology, biochemistry, and systems biology, we aim to highlight the unifying principles that underlie signaling-based regulation and to identify emerging directions for future research.

2. Materials and methods

2.1 Study Design and Conceptual Framework

This study was conducted as a narrative review aimed at synthesizing current knowledge on signal transduction pathways and post-translational modifications (PTMs) as regulators of cellular adaptation across diverse biological systems. Unlike systematic reviews designed primarily for quantitative aggregation, narrative reviews emphasize conceptual integration and mechanistic interpretation of the literature. This approach is particularly appropriate for molecular and cellular biology, where experimental heterogeneity, diverse model systems, and varying methodological approaches often limit the feasibility of large-scale quantitative meta-analysis.

The methodological framework of the present review was therefore designed to prioritize biological coherence, mechanistic synthesis, and thematic integration across disciplines including cancer biology, neurobiology, and microbial physiology. Particular attention was given to regulatory mechanisms involving phosphorylation and SUMOylation, which are widely recognized as key PTMs shaping protein activity, intracellular signaling networks, and adaptive responses to environmental stress (Cappadocia & Lima, 2018; Flotho & Melchior, 2013). These molecular mechanisms have been implicated in numerous physiological processes and pathological conditions, including tumor progression, neurodegenerative disease, and microbial pathogenicity (Anderson et al., 2017; Bray et al., 2024).

2.2 Literature Search Strategy

A comprehensive literature search was conducted to identify peer-reviewed publications addressing signal transduction pathways and PTM-mediated regulation of cellular processes. Electronic searches were performed in PubMed/MEDLINE, Web of Science, and Scopus, which collectively provide broad coverage of biomedical and life science literature. The search strategy combined controlled vocabulary terms and free-text keywords related to signal transduction, post-translational modification, phosphorylation, SUMOylation, kinase signaling, protein quality control, RNA processing, cellular stress responses, and microbial regulatory networks.

Search terms were connected using Boolean operators to increase retrieval sensitivity and specificity. Examples of key search combinations included “signal transduction AND post-translational modification,” “SUMOylation AND cellular stress,” and “phosphorylation signaling pathways AND disease.” Additional studies were identified through manual screening of reference lists from relevant reviews and primary research articles.

This broad search strategy was designed to capture literature across multiple biological contexts in which PTM-dependent signaling plays a regulatory role. For instance, studies describing phosphoproteomic approaches to identifying kinase substrates provided insight into signaling network architecture (DeMarco & Hall, 2023), whereas work on RNA processing regulation highlighted how signaling pathways coordinate transcriptional and post-transcriptional events (Ruta et al., 2021).

2.3 Study Selection and Eligibility Criteria

Publications identified through the search strategy were evaluated for relevance based on predefined inclusion criteria. Eligible studies were required to meet the following conditions:

• Publication in a peer-reviewed scientific journal.
• Investigation of molecular mechanisms involving signal transduction or PTM-mediated regulation.
• Experimental, observational, or integrative evidence related to cellular adaptation, stress responses, or disease mechanisms.
• Publication in English.

Both eukaryotic and prokaryotic systems were included to capture conserved regulatory principles across evolutionary lineages. For example, studies examining bacterial regulatory networks were considered relevant because microbial signaling systems often mirror the logic of eukaryotic signal transduction pathways (Dmitrenko et al., 2022; Foster et al., 2014).

Studies were excluded if they were limited to descriptive proteomic profiling without functional interpretation, or if they consisted of conference abstracts, editorials, commentaries, or non-peer-reviewed reports. Emphasis was placed on studies that provided mechanistic insight into signaling pathways, regulatory protein modifications, or the biological consequences of PTM dysregulation.

2.4 Screening and Data Extraction

Titles and abstracts retrieved from database searches were initially screened for relevance. Articles considered potentially eligible were then evaluated through full-text review. Information extracted from each study included the biological system investigated, the type of PTM examined, the signaling pathways involved, experimental models used, and the principal biological findings reported.

Data extraction focused on identifying recurring regulatory themes rather than generating standardized quantitative datasets. For example, studies describing SUMOylation-dependent regulation of transcriptional machinery were evaluated alongside research examining the role of SUMO enzymes in cancer pathogenesis (Jiaerken et al., 2024; Wild et al., 2024). Similarly, investigations of epigenetic co-regulators such as p300 were examined for their roles in integrating signaling pathways with transcriptional control (Gioukaki et al., 2023).

2.5 Narrative Synthesis and Thematic Integration

Because the studies included in this review employed diverse experimental systems—ranging from biochemical assays and structural analyses to genomic and cellular studies—substantial methodological heterogeneity was anticipated. Consequently, quantitative pooling of results was not considered appropriate for most datasets. Instead, findings were integrated through structured narrative synthesis, emphasizing mechanistic relationships and conceptual connections among studies.

Evidence was grouped into major thematic categories reflecting key regulatory processes. These included kinase-mediated signaling cascades, SUMOylation-dependent regulatory mechanisms, cross-talk between different PTMs, protein quality control systems, transcriptional and RNA-processing regulation, and adaptive signaling responses in microbial and multicellular organisms. This thematic organization allowed the integration of findings across biological scales while highlighting conserved regulatory principles.

For instance, PTM-mediated regulation of protein stability and aggregation has been implicated in neurodegenerative disorders through mechanisms involving protein quality control pathways (Gestwicki & Garza, 2012). In parallel, signaling-dependent transcriptional regulation plays an important role in oncogenic processes, reflecting the broader involvement of PTMs in disease-associated cellular reprogramming (Bray et al., 2024).

2.6 Evaluation of Evidence Quality

Although formal risk-of-bias tools are rarely standardized for mechanistic molecular biology research, studies included in this review were assessed qualitatively for methodological rigor and reliability. Criteria considered during evaluation included clarity of experimental design, reproducibility of assays, consistency of outcome measurements, and transparency of data interpretation.

Where applicable, attention was given to whether conclusions were supported by complementary experimental approaches, such as biochemical assays, genetic models, or systems-level analyses. This qualitative evaluation helped contextualize the strength of the evidence and identify areas where further experimental investigation may be required.

3. Results

3.1 Overview of Post-Translational Modifications in Cellular Adaptation

The literature synthesized in this review consistently identifies post-translational modifications (PTMs) as central regulatory mechanisms that allow cells to rapidly adjust to environmental and physiological challenges. Across diverse biological contexts—including cancer progression, microbial adaptation, stress responses, and RNA processing regulation—PTMs function as molecular switches that dynamically control protein activity, localization, stability, and interaction networks. Evidence from the reviewed studies indicates that phosphorylation, SUMOylation, acetylation, ubiquitination, and methylation collectively form a multilayered regulatory framework linking signal transduction pathways to adaptive cellular responses.

The biochemical machinery and biological functions of these PTMs are summarized in Table 2, which illustrates how distinct modification systems converge on common regulatory targets. Phosphorylation, mediated by kinase–phosphatase networks, is widely recognized as the most pervasive PTM controlling cellular signaling. High-throughput phosphoproteomic analyses have revealed thousands of phosphorylation events regulating transcription factors, metabolic enzymes, and RNA-processing proteins, demonstrating how kinase signaling rapidly translates extracellular cues into intracellular responses (DeMarco & Hall, 2023; Singh et al., 2017). These modifications frequently coordinate signaling cascades such as the ERK/MAPK and PI3K/AKT pathways, which govern proliferation, differentiation, and stress responses.

Complementing phosphorylation, SUMOylation plays a crucial role in maintaining genomic stability and regulating transcriptional activity. The SUMO conjugation machinery—comprising E1 activating enzymes, the E2 conjugating enzyme UBC9, and various E3 ligases—modifies numerous nuclear proteins, including transcription factors and DNA repair complexes (Flotho & Melchior, 2013; Geiss-Friedlander & Melchior, 2007). As summarized in Table 2, these modifications influence protein–protein interactions, chromatin organization, and cellular stress responses, reinforcing the concept that PTM cross-talk underlies many adaptive signaling processes.

3.2 Signal Transduction Pathways Regulating RNA Processing

Beyond regulating protein function directly, signal transduction pathways also influence gene expression through modulation of RNA processing mechanisms. Studies included in this review demonstrate that signaling pathways frequently intersect with alternative splicing (AS) and alternative polyadenylation (APA), enabling cells to reshape their transcriptomic landscape in response to environmental signals. The principal signaling pathways involved in these processes are summarized in Table 3.

For example, the PI3K/AKT pathway regulates alternative splicing of genes such as FGFR2 and PKCß, thereby influencing cell survival and tumor progression in malignant tissues (Naeem et al., 2022; Ruta et al., 2021; Lee & Rio, 2015). Similarly, the RAS/MAPK cascade controls splicing events involving CD44, RON, and Cyclin D1b, processes closely linked with epithelial-to-mesenchymal transition and metastatic potential in several cancers (Lavoie et al., 2020; Ruta et al., 2021). These findings illustrate how signal-dependent RNA processing extends the regulatory reach of PTMs beyond protein modification, allowing cells to modulate gene expression at multiple levels simultaneously.

Stress-related signaling pathways also contribute to adaptive RNA processing responses. The DNA damage response (DDR), mediated by kinases such as ATM and ATR, regulates splicing of genes involved in apoptosis and genome stability, including MDM2 and BCL-X. Likewise, heat shock signaling pathways trigger widespread intron retention, enabling cells to conserve energy while prioritizing synthesis of stress-response proteins. Collectively, these observations demonstrate that RNA processing mechanisms are tightly integrated with PTM-regulated signaling networks, forming an adaptive regulatory interface between environmental stimuli and gene expression programs.

3.3 PTM-Dependent Mechanisms in Disease Pathogenesis

The biological significance of PTM-regulated signaling becomes particularly evident in pathological contexts, where dysregulation of modification pathways contributes to disease development and progression. Table 4 summarizes key molecular adaptations identified across several disease systems.

In cancer biology, altered SUMOylation patterns have been implicated in the regulation of transcriptional repressors and oncogenic signaling pathways. In thyroid cancer, for example, aberrant SUMO modification of proteins such as CCDC6 promotes tumorigenesis by disrupting normal transcriptional regulation (Jiaerken et al., 2024; Seeler & Dejean, 2017). Similarly, acetylation-dependent activation of the transcriptional co-activator p300 enhances androgen receptor signaling and facilitates the TMPRSS2:ERG gene fusion frequently observed in prostate cancer (Gioukaki et al., 2023; Ianculescu et al., 2012). These findings highlight how PTM dysregulation can reshape transcriptional networks and promote malignant transformation.

Microbial systems provide further evidence for the evolutionary conservation of PTM-dependent regulatory strategies. In methicillin-resistant Staphylococcus aureus (MRSA), signaling pathways and genetic adaptations influence virulence factor expression and antibiotic resistance mechanisms (Dmitrenko et al., 2022; Foster et al., 2014). Similarly, quorum-sensing systems in Enterococcus species regulate transitions between commensal and pathogenic states through peptide-based signaling and post-translational processing (Sangiorgio et al., 2024). These examples demonstrate that PTM-regulated signaling is not restricted to eukaryotic cells but also plays critical roles in microbial physiology and pathogenesis.

3.4 Bioactive Peptides and PTM-Driven Molecular Diversity

In addition to regulatory signaling roles, PTMs contribute to the generation of structurally diverse bioactive molecules. Ribosomally synthesized and post-translationally modified peptides (RiPPs) represent a class of natural products whose biological activity depends on complex PTM-mediated structural transformations (Arnison et al., 2013; Hwang et al., 2025). The cytotoxic potency of selected plant-derived RiPPs across multiple cancer cell lines is summarized in Table 1.

Compounds such as RA-X, Rubipodanin A, and Moroidin exhibit distinct cytotoxic profiles against gastric, lung, cervical, and colon cancer cell lines. As illustrated in Figure 2, IC50 values vary substantially across compounds and cellular models, reflecting differences in molecular structure and mechanism of action. Rubipodanin A displays particularly strong cytotoxic activity in gastric cancer cells, whereas Moroidin demonstrates broader but comparatively moderate activity across several tumor types (Wang et al., 2015; Xu et al., 2022).

Figure 3 further visualizes these differences by comparing compound-specific cytotoxic activities, enabling cross-study interpretation of relative potency and variability. These observations support the concept that PTM-driven peptide cyclization and methylation significantly influence molecular conformation and biological activity. The ability of such peptides to induce apoptosis through caspase activation and mitochondrial dysfunction highlights their therapeutic potential in oncology (Hwang et al., 2025).

Finally, broader evolutionary perspectives on PTM-mediated regulation are reflected in studies of primitive catalytic peptides and microbial signaling molecules. For example, the organocatalytic activity of simple peptides such as serine–histidine dipeptides suggests that early biochemical systems may have exploited primitive PTM-like chemistry long before the emergence of modern enzymatic networks (Wieczorek et al., 2017). Collectively, the evidence summarized in Tables 1–4 and Figures 2–4 underscores the central role of PTMs in shaping biological complexity, from molecular evolution to disease pathology.

Table 1: Summary of Cytotoxic Potency of Plant-Derived RiPPs Across Human Cancer Cell Lines. This table presents IC50 values and associated variability for selected ribosomally synthesized and post-translationally modified peptides (RiPPs) tested against multiple cancer cell lines. These data provide the quantitative foundation for weighting and comparative analysis in the meta-analytical framework.

Table 2. Regulatory Mechanisms and Biological Impacts of Major Post-Translational Modifications (PTMs). This table outlines the biochemical machinery and functional consequences of primary post-translational modifications involved in cellular adaptation and homeostasis.

Table 3. Signal Transduction Pathways Coordinating Adaptive RNA Processing. This table summarizes how central signaling cascades translate external stimuli into adaptive cellular responses through regulation of alternative splicing (AS) and alternative polyadenylation (APA).

Table 4. Molecular Adaptations in Disease Pathogenesis: PTMs and Signaling Interactions. This table highlights how aberrant post-translational modifications and signaling pathways contribute to adaptive mechanisms in cancer progression and infectious disease persistence.

Figure 1. Comparative Distribution of Cytotoxic IC50 Values for Plant-Derived RiPPs Across Human Cancer Cell Lines

Figure 2. Cross-Study Comparison of Cytotoxic Activity of Plant-Derived RiPP Compounds. This figure integrates compound-specific cytotoxic activity to facilitate cross-study comparison and downstream forest plot construction. It complements tabulated IC50 data by emphasizing relative effect magnitude and dispersion

Figure 3. Evidence Distribution Across Antimicrobial Resistance and Adaptive Signaling Categories

4. Discussion

4.1 PTMs as Universal Regulators of Cellular Signaling

The findings synthesized in this review emphasize that post-translational modifications represent fundamental regulatory mechanisms underlying cellular adaptation. Across diverse biological systems, PTMs act as molecular switches that translate environmental signals into coordinated biochemical responses. The convergence of evidence summarized in Tables 2–4 indicates that phosphorylation, SUMOylation, acetylation, and related modifications collectively regulate protein function, gene expression, and cellular stress responses.

Among these mechanisms, phosphorylation remains the most extensively characterized PTM in signal transduction. Kinase-mediated signaling cascades such as the ERK/MAPK pathway function as hierarchical networks capable of amplifying extracellular signals and coordinating complex cellular behaviors (Lavoie et al., 2020; Singh et al., 2017). Through sequential phosphorylation events, these pathways regulate transcription factors, metabolic enzymes, and RNA-processing proteins, thereby linking external stimuli to intracellular regulatory programs (DeMarco & Hall, 2023).

However, phosphorylation rarely acts alone. Increasing evidence demonstrates that signaling outcomes often depend on combinatorial PTM networks in which multiple modifications cooperate to fine-tune protein activity. For instance, SUMOylation frequently interacts with phosphorylation through phosphorylation-dependent SUMO motifs, creating regulatory modules that integrate multiple signaling pathways (Hendriks et al., 2017; Wild et al., 2024). This layered architecture likely explains why PTM-mediated signaling exhibits such versatility across biological systems.

4.2 PTM Regulation of Gene Expression and RNA Processing

Another key insight emerging from this synthesis is the close relationship between PTM-regulated signaling pathways and RNA processing mechanisms. As illustrated in Table 3, several major signaling pathways directly influence alternative splicing and polyadenylation processes. These regulatory interactions enable cells to adjust gene expression programs rapidly without altering genomic DNA sequences.

Alternative splicing in particular provides a powerful mechanism for expanding proteomic diversity. Splicing regulators respond to phosphorylation events and chromatin modifications, thereby integrating signaling cues with transcript maturation processes (Black, 2003; Lee & Rio, 2015). Histone modifications further influence RNA processing by altering chromatin structure and transcriptional elongation rates, which in turn affect splice-site selection (Luco et al., 2011; Tian & Manley, 2016; Koksharova et al., 2021).

These regulatory interactions become especially important under conditions of cellular stress or disease. For example, activation of DNA damage response pathways can suppress normal RNA processing while promoting splicing patterns associated with apoptosis or DNA repair. Similarly, heat shock signaling alters phosphorylation states of splicing factors, enabling cells to prioritize synthesis of stress-response proteins while temporarily reducing general transcriptional activity.

4.3 PTM Dysregulation in Disease

The pathological consequences of PTM dysregulation are particularly evident in cancer and neurodegenerative diseases. As summarized in Table 4, aberrant SUMOylation and acetylation events frequently disrupt transcriptional control mechanisms, leading to altered gene expression programs that favor tumor growth and survival (Seeler & Dejean, 2017; Jiaerken et al., 2024).

In prostate cancer, for example, acetylation-dependent activation of the transcriptional co-activator p300 enhances androgen receptor signaling and facilitates oncogenic gene fusion events (Gioukaki et al., 2023; Ianculescu et al., 2012). Similar regulatory mechanisms have been observed in thyroid cancer, where abnormal SUMOylation patterns contribute to tumor progression by altering the localization and activity of transcriptional repressors (Jiaerken et al., 2024). Neurodegenerative disorders also illustrate the importance of PTM-regulated protein quality control mechanisms. SUMOylation can inhibit aggregation of proteins such as a-synuclein, suggesting that disruption of PTM pathways may contribute to toxic protein accumulation in neurodegenerative diseases (Krumova et al., 2011; Anderson et al., 2017). These findings highlight the broader role of PTMs in maintaining cellular proteostasis and preventing pathological protein aggregation.

4.4 Evolutionary and Microbial Perspectives

The conservation of PTM-regulated signaling across evolutionary lineages underscores its fundamental importance in biology. Bacterial signaling systems, including two-component regulatory pathways and quorum-sensing networks, rely on phosphorylation and peptide-mediated modifications to coordinate virulence, metabolism, and environmental adaptation (Dmitrenko et al., 2022; Sangiorgio et al., 2024). These systems enable pathogenic bacteria such as Staphylococcus aureus to regulate surface proteins involved in host adhesion and immune evasion, facilitating persistent infection (Foster et al., 2014; Enright et al., 2002).

Moreover, the evolutionary origins of PTM-mediated regulation may extend to primitive biochemical systems. Experimental studies have demonstrated that simple peptides can catalyze reactions involved in peptide and nucleic acid formation, suggesting that rudimentary PTM-like chemistry may have played a role in early molecular evolution (Wieczorek et al., 2017). While speculative, such findings offer intriguing insights into how modern signaling networks may have emerged from simpler biochemical precursors.

4.5 Translational Implications

Beyond fundamental biological insights, PTM-mediated signaling pathways also hold significant therapeutic potential. The development of kinase inhibitors in oncology demonstrates how targeting specific signaling nodes can effectively modulate disease-associated pathways. Similarly, increasing attention is being directed toward SUMOylation enzymes as potential therapeutic targets in cancer and inflammatory diseases (Seeler & Dejean, 2017; Wild et al., 2024). Bioactive peptides derived from PTM-dependent biosynthetic pathways further illustrate the translational relevance of these mechanisms. As shown in Table 1 and visualized in Figures 2 and 3, plant-derived RiPPs display potent cytotoxic activity against several cancer cell lines. The structural diversity generated through PTM-mediated cyclization and methylation allows these peptides to interact with multiple cellular targets, making them promising candidates for drug development (Hwang et al., 2025).

Taken together, the evidence reviewed here supports the concept that PTMs represent universal regulators linking environmental sensing with cellular adaptation. By integrating signal transduction pathways with transcriptional regulation, RNA processing, and metabolic control, PTMs provide the molecular flexibility necessary for organisms to respond dynamically to changing conditions. Continued exploration of PTM networks will therefore be essential for understanding both fundamental biological processes and the molecular basis of disease.

5. Limitations of the study

Several limitations should be considered when interpreting the findings summarized in this narrative review. First, the included studies encompass diverse experimental systems, including in vitro biochemical assays, cell culture models, animal studies, and microbial investigations. This heterogeneity can complicate direct comparison of results and may limit the generalizability of specific mechanistic conclusions. Second, many investigations focus on a limited number of well-characterized post-translational modifications, particularly phosphorylation and SUMOylation, while numerous emerging PTMs remain comparatively understudied. Third, the dynamic and context-dependent nature of PTM regulation is often difficult to capture in static experimental designs, meaning that temporal signaling events and transient modification states may be underrepresented in the literature. Additionally, narrative reviews inherently involve interpretative synthesis rather than quantitative meta-analysis, which may introduce some degree of selection bias. Future studies integrating multi-omics datasets, time-resolved proteomics, and standardized analytical frameworks will be important for clarifying the broader regulatory landscape of PTM-mediated signaling.

6. Conclusion

Signal transduction pathways and post-translational modifications represent fundamental regulatory systems that enable cells to perceive and respond to environmental change. Evidence synthesized in this narrative review demonstrates that phosphorylation, SUMOylation, and related modifications function as molecular switches that coordinate protein activity, gene expression, and stress responses across diverse biological contexts. Dysregulation of these pathways contributes to major diseases including cancer, neurodegenerative disorders, and microbial infections. At the same time, PTM-dependent mechanisms provide promising targets for therapeutic intervention and drug discovery. Continued exploration of PTM networks through integrative molecular and systems biology approaches will be essential for understanding cellular adaptability and translating these insights into biomedical innovation.

References